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Obese subcutaneous adipose 
tissue impairs human myogenesis, 
particularly in old skeletal muscle, 
via resistin-mediated activation of 
NFκB
Mary F. O’Leary1, Graham R. Wallace1, Edward T. Davis2, David P. Murphy3, 
Thomas Nicholson1, Andrew J. Bennett4, Kostas Tsintzas5 & Simon W. Jones1
Adiposity and adipokines are implicated in the loss of skeletal muscle mass with age and in several 
chronic disease states. The aim of this study was to determine the effects of human obese and lean 
subcutaneous adipose tissue secretome on myogenesis and metabolism in skeletal muscle cells 
derived from both young (18–30 yr) and elderly (>65 yr) individuals. Obese subcutaneous adipose 
tissue secretome impaired the myogenesis of old myoblasts but not young myoblasts. Resistin was 
prolifically secreted by obese subcutaneous adipose tissue and impaired myotube thickness and 
nuclear fusion by activation of the classical NFκB pathway. Depletion of resistin from obese adipose 
tissue secretome restored myogenesis. Inhibition of the classical NFκB pathway protected myoblasts 
from the detrimental effect of resistin on myogenesis. Resistin also promoted intramyocellular lipid 
accumulation in myotubes and altered myotube metabolism by enhancing fatty acid oxidation and 
increasing myotube respiration and ATP production. In conclusion, resistin derived from human obese 
subcutaneous adipose tissue impairs myogenesis of human skeletal muscle, particularly older muscle, 
and alters muscle metabolism in developing myotubes. These findings may have important implications 
for the maintenance of muscle mass in older people with chronic inflammatory conditions, or older 
people who are obese or overweight.
The loss of skeletal muscle mass with ageing (sarcopenia) is accompanied by an increased systemic inflamma-
tory burden1 and accumulation of adipose tissue2, which is known to be a prolific secretor of pro-inflammatory 
cytokines3 termed adipokines. Notably, the prevalence of sarcopenia is greater in obese than in non-obese older 
individuals4 and this association has been referred to as sarcopenic obesity5. Sarcopenic obesity is considered to 
be an important public health concern in the elderly as it confers a higher risk for developing disability in the 
muscle functional activities of daily living, culminating in reduced quality of life6. Significantly, sarcopenic obesity 
is associated with increased levels of systemic pro-inflammatory markers after adjusting for the presence of other 
pro-inflammatory states such diabetes and cancer7.
Cross-sectional studies of the body composition of individuals across the lifespan found that total adipose 
tissue mass8 and visceral adipose tissue (VAT) mass9 negatively correlated with skeletal muscle mass. Indeed, the 
cross-sectional Health, Aging, and Body Composition (Health ABC) study of 3075 men and women aged 70–79 
years demonstrated that those with high systemic concentrations of TNFα and IL-6 had a smaller mid-thigh 
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muscle cross-sectional area and decreased grip strength10. Furthermore, circulatory levels of adiponectin and 
resistin are increased in old individuals, compared to the young, and are inversely associated with muscle 
strength11.
Collectively, these studies indicate that sarcopenia in overweight and obese individuals is in part an 
adipokine-driven phenomenon. Indeed, increased adipocyte-derived pro-inflammatory cytokines and lipid 
metabolites may contribute to decreased regenerative capacity12 and myogenesis13 of skeletal muscle. The 
anti-myogenic and muscle atrophic actions of some adipokines (such as TNFα and IL-6) are well studied in 
this respect, with data from in vivo and in vitro studies implicating their role in mediating muscle loss14–22. 
Furthermore, a recent study demonstrated that TNFα exacerbates saturated fatty acid (palmitate)-mediated lipo-
toxicity of murine myoblasts23, indicating the importance of pro-inflammatory cytokines in the context of the 
adipose tissue inflammatory milieu. However, the functional effects of many other obesity-associated adipokines, 
including resistin, on human skeletal muscle are not well characterised. Furthermore, very few studies have exam-
ined the inflammatory milieu secreted by human subcutaneous adipose tissue (SAT).
Despite the prominent attention that visceral adipose tissue (VAT) has received as a secretor of adipokines, 
SAT also secretes pro-inflammatory adipokines, albeit to a lesser extent24–26. Importantly, SAT represents a much 
greater proportion of total adipose tissue mass than VAT27–29, and therefore may be greatly underappreciated 
as a contributor to the systemic inflammatory burden. To our knowledge, a single study has directly examined 
the effect of an inflammatory milieu secreted by human SAT adipocytes on primary human myotube morphol-
ogy24. This particular study showed that conditioned medium from SAT adipocytes derived from lean individuals 
does not alter the Myotube Thickness (MTT) or Nuclear Fusion Index (NFI) of myotubes in myogenic cultures 
isolated from a neonate24. Interestingly, adipocytes isolated from obese SAT showed an intermediary inflam-
matory profile and negative effect on MTT between lean SAT and obese VAT. In the same study, conditioned 
medium from obese VAT adipocytes significantly diminished MTT but not NFI when compared with control 
and lean SAT. Furthermore, direct co-culture of obese VAT adipocytes with myoblasts derived from a neonate, 
resulted in significant reduction in the expression of the myogenic transcription factors MyoD1 and myogenin. 
However, the study used adipocytes, rather than whole adipose tissue to generate conditioned medium represent-
ing the secretome, and thus did not characterise the effects of adipose tissue’s complete inflammatory milieu on 
myogenic cultures. Critically, the stromal vascular fraction of adipose tissue, which includes preadipocytes and 
macrophages, is a more prolific secretor of pro-inflammatory cytokines than mature adipocytes25. Furthermore, 
the myotubes used were neonate not from adult donors. Consequently, adipokine secretion by human adipose 
tissue – not just that by adipocytes – must be characterised and its effect on human myofibre size and function 
determined.
The aim of this study was therefore to determine the effects of lean and obese SAT conditioned media 
secretome, and in particular the adipokine resistin, concentrations of which are known to be increased in the 
serum of obese individuals30,31, on human skeletal muscle myogenesis and metabolism using muscle cell cultures 
derived from both old and young individuals.
Materials and Methods
Skeletal muscle biopsy and myogenic culture isolation. Three young healthy subjects (2 males and 
1 female; age 24.4 ± 1.5 yr; BMI 22.6 ± 2.2 kg/m2) and four elderly healthy individuals (2 males and 2 females; 
age 70.5 ± 2.8; BMI 21.8 ± 1.3 kg/m2) were recruited and gave written informed consent. All participants were 
physically active (at least 150 minutes of self-reported moderate intensity activity per week). Participants were free 
from cardiovascular, metabolic, neuromuscular or other diseases that might affect muscle growth and metabolism 
during screening. The study was approved by the University of Nottingham Medical School Ethics Committee 
(G11092014SoLS) and was conducted in accordance with the guidelines of the Declaration of Helsinki. A vastus 
lateralis muscle biopsy was obtained from each subject and the satellite cell population extracted as previously 
described32. Our isolation technique has consistently generated cultures in our laboratories that produce desmin 
positive multinucleated myotubes that are negative for the fibroblast marker TE732. Additionally, commercially 
available primary human myoblasts (Thermo Fisher cat. No. A12555), isolated from a female aged 21 yr were 
utilised for mechanistic studies, which were cultured in the same media and conditions as the cultures that we 
isolated in-house.
Generation of adipose conditioned medium secretome. Following ethical approval (UK National 
Research Ethics Committee 16/SS/0172), SAT was obtained intraoperatively from n = 13 lean (BMI < 25, age 
68.1 ± 3.3 years) and n = 22 non-lean (BMI > 25, age 69.5 ± 1.8 years) older individuals undergoing elective total 
joint replacement surgery at either the Royal Orthopaedic Hospital (Birmingham, UK) or Russell’s Hall Hospital 
(Dudley,UK). SAT was incubated in myotube differentiation medium at a ratio of 1 g tissue to 10 mL medium for 
24 h at 37 °C, 21% O2 and 5% CO2. Larger samples were divided into segments of ~1 g to ensure that the surface 
area of adipose tissue exposed to medium remained approximately constant. At 24 h the adipose conditioned 
medium (ACM) was removed, aliquoted into 5 mL sample containers and stored at −80 °C. For experimental 
use, the ACM was diluted 1:2 with differentiation medium, to ensure a sufficient nutrient composition to sustain 
myogenic differentiation.
Immunofluorescence staining. Myotubes were differentiated for 8 d in the presence of ACM secretome 
or recombinant resistin protein. The details of cytokine concentrations, as well as the timing and duration of such 
stimulations, are described in the relevant results section and Figure legend. Media were renewed every 2 d. The 
culture medium was removed and the cells fixed with 2% formaldehyde in PBS for 30 min. Following permea-
bilization in 100% methanol for 10 min, wells were blocked with 5% goat serum in PBS for 30 min. The primary 
antibody was diluted (Desmin, 1:1000, Dako) in 1% BSA/PBS and 150 μL was added per well for 1 hour. Wells 
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were subsequently incubated with 150 μL/well secondary antibody (Goat anti-Mouse IgG (H + L), Alexa Fluor® 
488 conjugated, Thermo Fisher) for 1 h in the dark. Each well was washed with PBS and 150 μL/well DAPI/PBS 
(1:5000, Cell Signalling Technology) was added for 5 min in the dark. Wells were further washed with PBS, a drop 
of mountant added to each well (ProLong Diamond Antifade, Thermo Fisher) and a coverslip applied.
Quantification of myotube thickness and nuclear fusion index. 24-well plates of immunuoflu-
oresence (IF) stained myotubes were imaged on an epifluorescence/brightfield microscope (Leica DMI6000). 
Triplicate wells were stimulated for each biological replicate and for each treatment condition. Multiple images 
were taken in each well for the quantification of myotube thickness (MTT) and nuclear fusion index (NFI). For 
quantification of MTT, 15 images per well were obtained using a 63x objective, the first image being obtained at 
a fixed starting point and subsequent images selected by moving to the next field of view in a predefined pattern. 
For assessment of NFI, 5 images per well were obtained in the same fashion, using a 20x objective. Image analysis 
was carried out by a blinded researcher, using Image J software. A myotube was defined as a desmin positive 
structure, containing 3 or more nuclei. The MTT of each myotube was calculated by taking the average of 5 
measurements obtained along its length. The NFI was defined as the number of nuclei clearly incorporated into 
myotubes expressed as a proportion of the total visible nuclei in each field of view.
Immunoblotting. Protein extraction, SDS-PAGE and immunoblotting were performed as previously 
described32. Primary antibodies for NFκB p65 (Cell Signalling Technology #6956), phosphorylated (Ser536) 
NFκB p65 (Cell Signalling Technology #3033) and resistin (polyclonal rabbit IgG, Thermo Fisher PA1-1049) 
were used. Anti-mouse (NA931V, GE Healthcare) and anti-rabbit (NA934, GE Healthcare) HRP-linked sec-
ondary antibodies were diluted 1:5000 in TBS-T, and blots were developed using ECL-plus (GE Healthcare, 
Amersham Biosciences, Amersham, UK) according to the manufacturer’s instructions. Bands were visualised on 
the ChemiDoc MP imaging system (Bio-Rad, UK).
Immunoprecipitation of resistin from adipose conditioned media. 70 μL Protein A Sepharose® 
beads (Abcam, ab193256) were incubated with 1 μg anti-resistin primary antibody (polyclonal rabbit IgG, 
Thermo Fisher PA1-1049) or 1 μg rabbit IgG isotype control (Sigma Aldrich, 12–370). The antibody-bead mix-
ture was incubated for 4 h at 4 °C on a shaker. The beads were centrifuged at 3,000 g for 2 min at 4 °C and the 
supernatant was discarded. Beads were then washed twice with PBS, 5 mL ACM added to each bead-antibody 
conjugate and the ACM-bead-antibody mixture incubated for 24 h at 4 °C with rotary agitation. The mixture 
was centrifuged at 3,000 g for 2 min at 4 °C and the supernatant (ACM) was retained and stored at −80 °C. The 
antibody-bead conjugates were washed in PBS as before. The antigen-antibody complexes were eluted from the 
sepharose beads by the addition of 50 μL 2x Laemmli sample loading buffer. The elutes were incubated at 50 °C for 
10 min and stored at −80 °C in advance of their use in immunoblotting for the detection of resistin.
Multiplex immunoassay. Cytokine and chemokine concentrations were quantified in ACM secretome 
by multiplex magnetic bead-based immunoassay (Luminex® Screening Assay, R&D Systems) according to the 
manufacturer’s instructions. 50 µL of a 1x antibody magnetic bead stock (Adiponectin, Serpin E1, Aggrecan, 
Amphiregulin, CCL11, CCL2, CCL3, CCL20, Chemerin, CXCL10, Dkk1, Galectin-1, gp120, IL-1β, IL-10, IL-15, 
IL-7, visfatin, TNFα, Galectin-3BP, Lipocalin-2, CCL4, FABP4, LIF, Leptin, IL-6, Resistin) was added to each well 
of a flat bottom black plate. 50 µL of undiluted sample or standard were added in duplicate to the plate. The plate 
was then sealed and incubated for 2 h on an orbital rotator. The plate was washed three times with a magnetic 
plate washer (Bio-Plex Pro™ Wash Station, Bio-Rad) using the wash buffer provided. 50 µL of a biotinylated 
antibody cocktail was added to each well; the plate was resealed and incubated for 1 h on the orbital rotator. The 
wash steps were repeated as before and 50 µL of the provided streptavidin-PE was added to the wells. The plate 
was incubated on the orbital rotator for 30 min and the wash steps repeated for a final time. Finally, the beads 
were resuspended in 200 µL wash buffer and the analytes were quantified by the Luminex® 200 multiplex analyser 
(Luminex® Corporation).
Oil Red O staining for assessment of intramyocellular lipid content (IMCL). Oil Red O staining 
was carried out on 24-well plates of myotubes that had been previously IF stained using a protocol adapted from 
Koopman et al.33. In brief, the wells were first washed 3 times with PBS. An Oil Red O stock solution (0.5% (w/v) 
Oil red O in 60% triethyl-phosphate in ddH2O) was diluted 3:2 in double distilled (dd)H2O, and filtered through 
a 0.22 µM filter. 150 μL Oil Red O working solution was added to each well for 1 h. The wells were washed as before 
in PBS, a drop of mountant (ProLong Diamond Antifade, Thermo Fisher) added to each well and a coverslip 
applied. Brightfield imaging was carried out on a microscope (Leica DMI6000). The Oil Red O positive area was 
quantified by Image J analysis. Briefly, each image was converted to a grayscale 8-bit format and the threshold 
was adjusted to highlight pixels of intensity between 90–110. The total Oil Red O area of this binary image was 
calculated by Image J.
Seahorse XFe96 analysis of myotube metabolic function. A Seahorse XFe96 analyser (Agilent 
Technologies, Santa Clara, California, United States) was used to conduct a Seahorse XF Mito Stress Test in 
accordance with the manufacturer’s recommendations. Myoblasts (2.5 × 104 cells per well) were seeded to 0.2% 
gelatin-coated Seahorse XFe96 Cell Culture Microplates. At 24 h the cells were differentiated. Treatment con-
ditions were assayed in quadruplicate and the assay was run at differentiation day 8. The XF Cell Mito Stress 
Test was also modified by the addition of Seahorse XF Palmitate-BSA FAO Substrate to allow the measurement 
of endogenous and exogenous fatty acid oxidation; this procedure was carried out according to the manufac-
turer’s instructions. Relative mitochondria content was determined by staining myotubes for 24 h with 100 nM 
Mitotracker (ThermoFisher, UK).
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Statistical analysis. Data analysis was carried out using IBM SPSS Statistics 21. All data are presented as 
means ± SEM of biological replicates. The normality of data was established by a Shapiro-Wilk test, whereas 
Levene’s test was used to establish equality of variances. For parametric data involving two treatment condi-
tions unpaired t tests were used. Non-parametric data were analysed by Mann-Whitney U tests. Where data 
involving more than two treatment conditions were normally distributed, comparison was performed by a 
one-way or two-way analysis of variance (ANOVA) with post-hoc Bonferroni correction. Where such data were 
non-parametric, differences between conditions were analysed by Mann–Whitney U test with post-hoc Holm’s 
sequential Bonferroni correction. A p value of <0.05 was considered statistically significant. Details of the statis-
tical tests used for each data set can be found in the relevant figure legend.
Results
Quantification of adipokine in the secretome of subcutaneous adipose tissue from lean and 
non-lean individuals. We initially profiled the concentrations of 22 adipokines in SAT conditioned media 
(ACM) collected from a cohort of normal weight (BMI < 25, n = 13) and overweight/obese (BMI > 25, n = 22) 
older individuals by multiplex magnetic bead-based immunoassays (Table 1).
Comparing the ACM from the 2 groups, there was no significant difference in the concentration of the prom-
inent adipokines leptin and adiponectin, the concentration of well-known pro-inflammatory cytokines IL-1β 
and IL-6, or in the concentration of the anti-inflammatory cytokine IL-10. However, the mean concentration of 
resistin was significantly greater (p < 0.05) in the ACM from overweight/obese older individuals (1778 ± 109 pg/
mL) compared to the ACM collected from normal weight older individuals (1207 ± 225 pg/mL). Furthermore, 
the median concentration of serpin E1 was significantly greater (p < 0.05) in the ACM from overweight/obese 
(median = 10565, IQR = 3420–13450 pg/mL) compared to the ACM from normal weight older individuals 
(median = 4156, IQR = 1337–6761 pg/mL). Of note, there was also a trend for the median concentration of fatty 
acid binding protein 4 (FABP4) to be lower in overweight/obese ACM compared to the normal weight, although 
this did not reach significance (Table 1).
Obese subcutaneous adipose tissue secretome impairs human myogenesis of old, but not 
young, muscle cells. Having determined the concentrations of adipokines secreted from lean and non-lean 
SAT, we then sought to determine the effect of the ACM secretome derived from the SAT of normal weight (NW, 
Lean (BMI < 25)
(Mean ± SEM, pg/mL)
Non-Lean (BMI > 25)
(Mean ± SEM, pg/mL)
P-value
(Lean vs. non-
lean)
Adiponectin 28716 ± 4524 28841 ± 3779 0.18
Aggrecan 578, 559–606 530, 468–567 0.07¶
Amphiregulin 532 ± 137 703 ± 67 0.22
Chemerin-1 2655 ± 673 3450 ± 583 0.44
Eotaxin 95 ± 41 61 ± 12 0.81
FABP4 38 × 104, 27 × 104–81 × 104 27 × 104, 23 × 104–39 × 104 0.06¶
Galectin-1 5.3 × 104 ± 0.6 × 104 5.2 × 104 ± 0.3 × 104 0.85
GP130 29001 ± 10480 31824 ± 7342 0.83
IL-10 2.25 ± 0.56 2.59 ± 0.39 0.62
IL-15 1.81 ± 0.52 2.32 ± 0.37 0.45
IL-1β 12.02 ± 1.59 11.94 ± 1 0.96
IL-6 507, 436–1044 1528, 719–2889 0.12¶
IL-7 3.02 ± 0.27 3.04 ± 0.29 0.96
Leptin 11335 ± 2592 12210 ± 2467 0.83
MCP-1 2372 ± 924 1540 ± 406 0.34
MIP1a 363 ± 54 303 ± 32 0.33
MIP1b 101 ± 37 125 ± 24 0.58
MIP3a 85 ± 25 164 ± 51 0.97
Resistin 1207 ± 225 1778 ± 109 0.01
Serpin E1 4156, 1337–6761 10565, 3420–13450 0.02¶
TNFα 10.43 ± 1.57 10.43 ± 1.17 0.99
Visfatin 114, 1007–1827 917, 2051–2417 0.91¶
Table 1. The Inflammatory Secretory Profile of Normal weight (Lean) and overweight/obese (non-Lean) 
Subcutaneous Adipose Conditioned Medium. Adipokine concentrations were determined by multiplex 
magnetic bead-based cytokine assays in ACM from lean (BMI < 25, n = 13) and non-lean (BMI > 25, 
n = 22) subjects. Data are presented as mean ± SEM where normally distributed and as median, 25th 
percentile-75th percentile where not normally distributed (marked¶). FABP4 = Fatty acid binding protein 4, 
GP130 = glycoprotein 130, MCP-1 = Monocyte chemoattractant protein 1, MIP1a = Macrophage inflammatory 
protein 1a, MIP1b = Macrophage inflammatory protein 1b, MIP3a = Macrophage inflammatory protein 3a. 
IL = Interleukin; TNFα = Tumor Necrosis Factor alpha.
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BMI < 25) and obese (OB, BMI > 30) individuals on myotube formation. Subconfluent myoblasts from young 
and old lean, healthy subjects (n = 3 per group) were switched to unconditioned differentiation medium, NW 
ACM or OB ACM. Each young biological replicate was stimulated together with one from the old experimental 
group such that both young and old replicates were stimulated with the same NW and OB ACM sample. Media 
were renewed every 2 d. At 8 d, myotubes were fixed, IF stained for desmin and DAPI and imaged on an epifluo-
rescence microscope (Fig. 1A).
Myotubes from elderly subjects that were stimulated with OB ACM (Fig. 1B) were 30% thinner (19.1 ± 1.3 µm) 
compared to their NW ACM counterparts (27.4 ± 2.5 µm, p < 0.01). The relative changes in myotube thickness 
(MTT) were mirrored by measurements of myotube area (Supplementary Fig. 1). The NFI of elderly myo-
genic cultures (Fig. 1C) was also significantly diminished by OB ACM (20.4 ± 1.9%) compared to NW ACM 
(35.7 ± 2.0%,p < 0.001). Young myotubes were not significantly affected by stimulation with the same ACM sam-
ples, although a trend (p = 0.09) of reduced NFI was observed when incubated with OB ACM (Fig. 1B,C).
The adipokine resistin impairs human myogenesis. Since the adipokine resistin was significantly ele-
vated in the ACM of overweight/obese individuals, we next examined the effect of stimulating myoblasts with 
recombinant resistin during their differentiation to myotubes. Subconfluent myoblasts from young (n = 3) and 
elderly (n = 3) subjects were switched to differentiation media or differentiation media containing recombinant 
resistin (5 ng/mL). The concentration of 5 ng/mL resistin was chosen since it represented the upper end of those 
concentrations observed in OB ACM. Media were renewed every 2 d. At 8 d, cultures were fixed, IF stained 
for desmin and with DAPI, imaged on an epifluorescence microscope and MTT and NFI were quantified as 
previously described. Resistin significantly reduced MTT in both young (25.0 ± 1.8 µm unstimulated control vs 
Figure 1. Obese subcutaneous adipose conditioned medium inhibits myotube formation in differentiating 
human myoblasts. Subconfluent myoblasts were switched to unconditioned differentiation medium or 
differentiation medium that had previously been conditioned with adipose tissue from normal weight (NW 
ACM, n = 3; BMI < 25 kg/m2) or obese individuals (OB ACM, n = 3; BMI > 30 kg/m2). Each young (18–30 yr) 
biological replicate was paired with one from the old (>65 yr) experimental group, with both being stimulated 
with the same ACM samples. Media were renewed every 2 d. At 8 d, myotubes were fixed, immunofluorescence 
stained for desmin and with DAPI and imaged on an epifluorescence microscope. (A) Representative images 
at 20x magnification. (B) Myotube thickness data represent the mean ± SEM of n = 3 biological replicates. 
Each biological replicate comprises 150 total measurements taken at 63x magnification from 30 myotubes per 
treatment condition. (C) Nuclear fusion index data are expressed as mean ± SEM values of n = 3 biological 
replicates. Each biological replicate comprises 15 images taken at 20x magnification. **p < 0.01, ***p < 0.001 
by Mann-Whitney U test with post-hoc Holm’s sequential Bonferroni adjustment.
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20.4 ± 1.2 µm resistin stimulated, p < 0.05) and old (25.9 ± 2.2 µm unstimulated control vs 20.8 ± 1.7 µm resis-
tin stimulated, p < 0.05) myogenic cultures (Fig. 2A). Resistin significantly diminished NFI in old cultures only 
(40.1 ± 3.2% unstimulated control vs 30.2 ± 4.3% resistin stimulated, p < 0.001) (Fig. 2B).
Depletion of resistin from obese subcutaneous adipose tissue secretome improves myogene-
sis. The effect of resistin on myogenesis was then validated by depletion of resistin from OB ACM secretome 
by immunoprecipitation. Firstly, in order to confirm the success of the immunoprecipitation, antibody conjugates 
were lysed and analysed by Western blotting for the detection of bound resistin (Fig. 3A). Resistin was detected 
in the resistin antibody conjugates lysates but not in the IgG control conjugate lysates (Fig. 3A). Secondly, the 
OB ACM was analysed before and after resistin immunoprecipitation for the concentration of resistin by ELISA, 
employing a different anti-resistin antibody than the immunoprecipitation procedure. Resistin concentrations in 
OB ACM were diminished following resistin immunoprecipitation, to a level similar to that found in NW ACM 
(Fig. 3B).
To examine the effect of resistin-depleted OB ACM secretome on myogenesis we utilised commercially avail-
able primary human myoblasts, which we first validated as responding in a similar way to our in-house cultures 
(Supplementary Fig. 2). Myoblasts were then switched to differentiation media containing either normal OB 
ACM, or resistin-depleted OB ACM. Media was renewed every 2 days as previously performed and myotubes 
fixed and stained at 8 days for the quantification of MTT and NFI. Myoblasts cultured with the resistin-depleted 
OB ACM exhibited significantly increased MTT (30.8 ± 2.8 µm vs 20.1 ± 1.3 µm, p < 0.05) and NFI (43.8 ± 4.5% 
vs 27.4 ± 3.9%, p < 0.05), compared to normal OB ACM (Fig. 3C,D).
Resistin inhibits myogenesis by activation of the classical NFκB pathway. Classical NFκB path-
way signalling is a negative regulator of myogenesis34,35. Furthermore, in multiple cell types, resistin has been 
shown to activate NFκB signalling36–38. Therefore, we next investigated whether the resistin-mediated effects on 
myogenesis were via NFκB activation.
Myogenic cultures differentiated for 48 h in the presence of OB ACM induced the phosphoryla-
tion (serine536) of p65 (p-p65), which was inhibited by the IKKβ inhibitor 5-(p-Fluorophenyl)-2-ureido]
thiophene-3-carboxamide (TPCA-1; Supplementary Fig. 3). Similarly, myogenic cultures differentiated for 48 h 
in the presence of 5 ng/mL recombinant resistin also displayed a significant increase in p65 phosphorylation; such 
phosphorylation was inhibited by the addition of TPCA-1 (Fig. 4A,B). Having established that resistin activates 
the classical NFκB signalling pathway during myogenesis, the ability of TPCA-1 to rescue myotubes from the 
anti-myogenic actions of resistin was explored. As before, 8 d resistin stimulation of differentiating myogenic 
cultures significantly diminished MTT and NFI, a phenomenon that was completely reversed by co-incubation 
with TPCA-1 (Fig. 4C,D).
Resistin is a metabolic stressor of developing myotubes. Myogenic differentiation is associated with 
mitochondrial biogenesis and an increased reliance on oxidative phosphorylation34,39. Furthermore, alterations in 
myogenic differentiation capacity and mitochondrial function often coexist40–42. Therefore, a Seahorse® XF Mito 
Stress Test was conducted on myotubes that had been differentiated for 8 d with or without the presence of 5 ng/
Figure 2. Recombinant resistin impairs myotube formation in myotubes derived from young and elderly 
subjects. Subconfluent myoblasts from young and elderly subjects were switched to differentiation media 
(with or without 5 ng/mL recombinant resistin). Media were renewed every 2 d. At 8 d, myotubes were fixed, 
immunofluorescence stained for desmin and with DAPI and imaged on an epifluorescence microscope. (A) 
Myotube thickness data represent the mean ± SEM of n = 3 biological replicates. Each biological replicate 
comprises 150 total measurements taken at 63x magnification from 30 myotubes per treatment condition. (B) 
Nuclear fusion index data are expressed as mean ± SEM values of n = 3 biological replicates. Each biological 
replicate comprises 15 images taken at 20x magnification. *p < 0.05, ***p < 0.001 by unpaired t test.
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mL recombinant resistin (Fig. 5A). Resistin increased basal respiration (9.0 ± 0.4 vs 6.1 ± 0.2 pmoles/min/µg, 
p < 0.0001), maximal respiration (12.1 ± 0.7 vs 8.9 ± 0.4 pmoles/min/µg, p < 0.001), ATP production (4.6 ± 0.2 
vs 2.3 ± 0.3 pmoles/min/µg, p < 0.0001), extracellular acidification rate (ECAR; 1.64 ± 0.10 vs 1.33 ± 0.05 mpH/
min/µg, p < 0.05) and proton leak (0.82 ± 0.09 vs 0.43 ± 0.11 pmoles/min/µg, p < 0.01), compared to unstimu-
lated control (Fig. 5B–G). However, we observed no significant difference in mitochondrial number between 
unstimulated and resistin stimulated myotubes, as determined using Mitotracker (Supplementary Fig. 4).
Oil Red O staining of similarly stimulated myotubes at 8 d, demonstrated IMCL accumulation under resis-
tin stimulation, with an increase in Oil Red O area (37 ± 3.5 vs 26 ± 3.1 mm2, p < 0.05) and Oil Red O par-
ticle size (8.8 ± 0.5 vs 6.5 ± 0.2 µm2, p < 0.01), compared to unstimulated controls (Fig. 6A,B). A Seahorse XF 
Palmitate-BSA FAO Substrate Mitochondrial Stress Test, carried out on a Seahorse XFe96 extracellular flux 
analyser demonstrated that resistin, compared to unstimulated control, significantly increased exogenous 
(0.15 ± 0.03 vs 0.02 ± 0.01 pmoles/min/µg, p < 0.01) fatty acid oxidation by myotubes (Fig. 6C) and promoted 
endogenous fatty acid oxidation, a phenomenon that was not detectable in unstimulated cultures (Fig. 6D).
Discussion
In this study, we describe for the first time the adverse myogenic effects of the obese human SAT secretome, 
generated using conditioned media. The stromal vascular fraction of adipose tissue is a more prolific secretor of 
pro-inflammatory cytokines than mature adipocytes25 and thus our experimental model may be a more physio-
logically relevant model of adipose tissue adipokine secretion than models which rely upon adipokine secretion 
Figure 3. Immunoprecipitation of resistin from obese subcutaneous adipose conditioned medium secretome 
(OB ACM) improves myogenesis. Resistin was immunoprecipitated from OB ACM using resistin antibody-
agarose bead conjugates (OB ACM – resistin IP). IgG isotype antibody control-agarose bead conjugates were 
used on the same samples as a control (OB ACM). (A) Resistin protein is detected by immunoblotting of 
resistin-antibody lysates but not IgG control lysates following immunopreciptation. Full sized western blot 
included in Supplementary Fig. 6. (B) Depletion of resistin in OB ACM following resistin immunoprecipitation 
as determined by ELISA. The dotted horizontal line illustrates the reference value of 1207 pg/mL for the 
concentration of resistin in NW ACM. (C) Subconfluent, commercially available primary human skeletal 
myoblasts from a female aged 21 yr were switched to either OB ACM differentiation media (OB ACM, n = 4) 
or to resistin-depleted OB ACM differentiation media (OB ACM Resistin IP, n = 4). Media were renewed 
every 2 d. At 8 d, myotubes were fixed, immunofluorescence stained for desmin and with DAPI and imaged 
on an epifluorescence microscope. Nuclear fusion index data are expressed as mean ± SEM values of n = 3 
independent experiments. Each independent experiment comprises 15 images taken at 20x magnification. 
(D) Myotube thickness data represent the mean ± SEM of n = 3 independent experiments. Each independent 
experiment comprises 150 total measurements taken at 63x magnification from 30 myotubes per treatment 
condition. *p < 0.05 vs OB ACM by unpaired t test.
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by adipocytes alone24. Furthermore, since SAT represents a much larger proportion of total adipose tissue mass 
than VAT27–29, its contribution to the systemic inflammatory burden to which skeletal muscle is exposed is likely 
to be significant. Indeed, myotubes from elderly subjects cultured with obese SAT secretome were 30% thin-
ner and had a 40% reduction in the number of nuclei incorporated into myotubes, compared to those cultured 
with normal weight SAT conditioned media. Previous work by Pellegrinelli et al. demonstrated that the lean 
subcutaneous adipocyte inflammatory secretome does not have a detrimental effect on myotube formation in 
neonatal myogenic cultures, but that the obese VAT adipocyte secretome does inhibit myotube formation in 
such cultures24. Interestingly, adipocytes isolated from obese SAT showed an intermediary negative effect on 
MTT between lean SAT and obese VAT24. Our work builds on these observations by the inclusion of both lean 
and obese SAT inflammatory milieu, using whole adipose tissue rather than adipocytes to generate conditioned 
medium and by demonstrating an anti-myogenic effect of OB ACM on elderly (but not young) adult human 
myogenic cultures. Our results suggest that younger skeletal muscle may be intrinsically more resilient to inflam-
matory cytokines secreted from SAT.
In considering potential secretory factors that could be - at least in part - responsible for the effect of the obese 
SAT secretome on myogenesis, the concentration of resistin was found to be significantly elevated in the SAT 
conditioned media secretome collected from non-lean (BMI > 25) older individuals, compared to that collected 
from lean (BMI < 25) older individuals. Resistin is a pro-inflammatory adipokine that is produced predominantly 
by monocytes and macrophages in humans, with a smaller proportion being produced by adipocytes43. Given the 
importance of adipose tissue M1 macrophage accumulation in ageing and obesity44–47, adipose tissue secretion 
of resistin may be of significant consequence in sarcopenia. However, few studies have previously described the 
effect of resistin on human skeletal muscle and sarcopenia. Plasma resistin concentrations have been reported to 
Figure 4. Resistin exerts its anti-myogenic effects via activation of the classical NFκB pathway. (A,B) 
Subconfluent primary human skeletal myoblasts from a female aged 21 yr were switched to differentiation 
media (with or without 5 ng/mL recombinant resistin ±40 nM TPCA-1) for 48 h. Phospho-p65 
(Ser536) and total p65 were detected by immunoblotting. US = unstimulated, R = resistin, T = TPCA-1, 
RT = resistin + TPCA-1. Data are expressed as mean ± SEM values of n = 4 independent experiments. *p < 0.05 
by one-way ANOVA with post-hoc Bonferroni correction. Full sized western blot included in Supplementary 
Fig. 7. (C,D) Subconfluent primary human skeletal myoblasts from a female aged 21 yr were switched to 
differentiation media (with or without 5 ng/mL recombinant resistin ± 40 nM TPCA-1). Media were renewed 
every 2 d. At 8 d, myotubes were fixed, immunofluorescence stained for desmin and with DAPI and imaged 
on an epifluorescence microscope. Myotube thickness data represents the mean ± SEM of n = 3 independent 
experiments. Each independent experiment comprises 150 total measurements taken at 63x magnification 
from 30 myotubes per treatment condition. Nuclear fusion index data are expressed as mean ± SEM values of 
n = 3 independent experiments. Each independent experiment comprises 15 images taken at 20x magnification. 
**p < 0.01, ***p < 0.001 vs unstimulated control by Mann-Whitney U test with post-hoc Holm’s sequential 
Bonferroni adjustment.
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have an inverse relationship with quadriceps torque in old (69–81 yr), but not in young (18–30 yr), subjects11. A 
recent study has described an inverse relationship between abdominal skeletal muscle density and systemic resis-
tin concentrations48; such increases in skeletal muscle density are thought to indicate improved muscle quality 
and have been associated with increased muscle strength49. Furthermore, C2C12 mouse myoblast proliferation 
is increased by the transfection of a human resistin eukaryotic expression vector, and such transfection reduces 
the expression of desmin and results in thinner myotubes50. We thus identified resistin as warranting further 
exploration of its myogenic effects.
Here, we demonstrate that stimulation of developing myotubes with recombinant resistin, at a concentra-
tion reported physiologically in older humans30, has a substantial detrimental effect on the formation of such 
myotubes. Notably, myogenic cultures from both young and old subjects were thinner following resistin stim-
ulation, but only old myotubes displayed a reduction in their NFI. Similarly, obese SAT conditioned media that 
contained more resistin had a greater detrimental effect on both myotube thickness and NFI of elderly myotubes 
compared to young myotubes. This might indicate that there are age-related differences in the ex vivo myogenic 
capacity of myoblasts under inflammatory conditions, with young muscle being more resistant to pathological 
levels of adipokines such as resistin than older muscle. The mechanisms underlying the differential responses 
of young and elderly myotubes to OB ACM were not explored in this study, yet plausible avenues of enquiry 
Figure 5. Resistin is a metabolic stressor of developing human myotubes. Subconfluent primary human skeletal 
myoblasts from a female aged 21 yr were switched differentiation media (with or without 5 ng/mL recombinant 
resistin). Media were renewed every 2 d. At 8 d, an XF Mito Stress Test was carried out on the Seahorse XFe96 
analyser. (A) Shows the timecourse profile of Oxygen Consumption Rate (OCR) during a Mito stress test (where 
oliogomycin, FCCP, Antimycin A and rotenone are added sequentially) in unstimulated and resistin stimulated 
myoblasts. (B–G) Show the calculated mean values of basal respiration, maximal respiration, ATP production, 
spare capacity, baseline ECAR and proton leak in unstimulated and resistin stimulated myoblasts. Data are 
expressed as mean ± SEM values of n = 4 independent experiments. Each independent experiment comprises 
data from quadruplicate measurements. *p < 0.05, **p < 0.01 ***p < 0.001 by Mann Whitney U test.
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exist. Primary human myogenic cultures are known to retain some of the characteristics of their donors51–53. 
Furthermore, aged skeletal muscle displays increased classical NFκB pathway activity54,55. It is possible altered 
cytokine receptor expression levels leave elderly myogenic cultures more susceptible to the detrimental effects of 
OB ACM on culture differentiation. However, we are unaware of any comprehensive profile of cytokine receptor 
gene or protein expression comparing young and old human skeletal muscle.
Given these findings, it is highly significant that depletion of resistin from obese SAT secretome reduced the 
anti-myogenic action of obese SAT conditioned media secretome. However, it is important to note that there 
are likely to be additional factors within obese SAT conditioned media, which we did not assess, that could have 
contributed to the considerable declines in both myotube thickness and NFI we observed in elderly myotube cul-
tures. Indeed, the recent paper by Saini et al.23, highlighted that the combination of pro-inflammatory cytokines 
and saturated fats can exacerbate anti-myogenic activity, suggesting that in vivo it is likely that it is the complex 
interactions between multiple factors within the adipose tissue inflammatory milieu that mediate muscle decline.
It is clear from the literature that resistin activates NFκB signaling. Such activation has been demonstrated in 
the HepG2 cells36, human coronary artery endothelial cells38 and in human macrophages37. Importantly, genetic 
approaches have now established the classical NFκB pathway as a negative regulator of myogenesis. Myogenesis 
has been shown to be enhanced in p65−/− myoblasts34, whilst the IKKβ inhibitor IV has been shown to enhance 
the myogenic differentiation of primary murine cultures from wild-type mice35. Furthermore, NFκB activation in 
the satellite cells of aged mice inhibited skeletal muscle regeneration in response to cryoinjury56.
In myogenic cultures, classical NFκB pathway activity is diminished at 48 h post-differentiation34. Importantly, 
we observed that the addition of recombinant resistin to our myogenic cultures resulted in persistent p65 phos-
phorylation (indicative of NFκB activation) at 48 h, a phenomenon that was reversed by the addition of the IKK2 
inhibitor TPCA-1. Importantly, TPCA-1 rescued the differentiation of our myogenic cultures in the presence of 
Figure 6. Recombinant resistin stimulation of developing myotubes from commercially available primary 
human skeletal myoblasts causes an accumulation of IMCL. Subconfluent primary human skeletal myoblasts 
from a female aged 21 yr were switched differentiation media (with or without 5 ng/mL recombinant resistin). 
Media were renewed every 2 d. (A,B) At 8 d, myotubes were fixed, permeabilised in 0.2% Triton X and stained 
with Oil Red O. Myotubes were imaged on a brightfield microscope and the Oil Red O positive area was 
quantified using Image J software. Data are expressed as mean ± SEM values of n = 3 independent experiments. 
Each independent experiment replicate comprises data from 15 images taken at 20x magnification. *p < 0.05, 
**p < 0.01 by t test. (C,D) At 8 d an XF palmitate-BSA FAO mitochondrial stress test was carried out on the 
Seahorse XFe96 analyser. Data are expressed as mean ± SEM values of quadruplicate measurements. **p < 0.01 
by t test.
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recombinant resistin, suggesting therefore that resistin impaired myogenesis via activation of the classical NFκB 
pathway.
We further observed that resistin promoted the accumulation of IMCL in human myotube cultures, as well as 
promoted an increased reliance on fatty acid oxidation to sustain an overall increase in metabolic activity, which 
may reflect the presence of cellular metabolic stress. None the less, the increase in myotube metabolic activity in 
the presence of diminished myotube formation is surprising. Since we observed no difference in mitochondria 
number between resistin stimulated and unstimulated myotubes, the increase in respiration could be indicative 
of metabolic stress. Indeed, futile substrate cycling between de novo lipogenesis and fatty acid oxidation had been 
previously reported in ex vivo murine skeletal muscle upon stimulation with the adipokine leptin57, and might 
partly explain our observations. It must be noted however that de novo lipogenesis is thought to be limited under 
normal physiological conditions in skeletal muscle58. The observation of increased fatty acid oxidation and IMCL 
accumulation is in agreement with reports of lipid accumulation in resistin-stimulated human macrophages59 
and of hepatic steatosis in resistin-treated mice36. Therefore, our observation of enhanced exogenous fatty acid 
oxidation and accumulation of IMCL in human myotubes under resistin stimulation conditions, coupled with 
observations by others that resistin stimulation of human macrophages promotes IMCL accumulation and the 
cell surface expression of the fatty acid transporter CD3659, suggests that enhanced fatty acid uptake – in excess 
of its increased oxidation by human myotubes – is responsible for the IMCL accumulation described in the pres-
ent study. Dysfunctional intramyocellular fatty acid handling and IMCL accumulation are associated with both 
skeletal muscle insulin resistance60,61, and anabolic resistance62. Furthermore, an increase in lipid content in type 
I fibres appears to be a feature of sedentary, but not physically active ageing63. The effect of IMCL accumulation on 
skeletal myogenesis is less well established, but O-GlcNAcylation, a post-translational modification that is asso-
ciated with obesity and diabetes, has a detrimental effect on C2C12 myogenesis40. Given these findings, the func-
tional effects of resistin on muscle metabolism we report here may have important implications. However, further 
studies are required to elucidate the mechanism by which resistin impacts on muscle metabolism by investigating 
the precise nature of the relationship between the myogenic and metabolic responses to resistin stimulation in 
human muscle cells and their importance for substrate regulation and insulin action.
This study has some limitations. Firstly, our young and elderly participants were recruited for biopsies at 
different times. Therefore, it was not possible to directly compare the differences between elderly and young base-
line NFI and MTT. Whilst we made every effort to standardise culture conditions, differences in media serum 
batches could have impacted on the myogenic differentiation. Thus, in this study we have restricted our statistical 
analysis of the data to comparing datasets to their own controls (unstimulated vs resistin). Secondly, we sourced 
commercially available myoblasts to complete the validation of resistin on myogenesis in the absence of access to 
further skeletal muscle biopsies. These commercial cells were isolated from a young person and were validated as 
sensitive to the anti-myogenic effects of resistin. In summary, our studies describe a detrimental effect of obese 
SAT conditioned media secretome on primary human myogenesis and identify resistin as the adipokine that - at 
least in part - mediates this effect. Furthermore, we demonstrate that resistin exerts its anti-myogenic effects by 
causing persistent activation of the classical NFκB pathway, and alterations in muscle metabolism. These findings 
may have important implications for the maintenance of muscle mass and metabolic control in older people who 
are obese or overweight, or those with chronic conditions such as osteoarthritis30 and type 2 diabetes64, which are 
associated with increased levels of resistin in the circulation.
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